Item 1.01. | Entry Into a Material Definitive Agreement. |
On October 31, 2018, Odyssey Marine Exploration, Inc. (“Odyssey”) and certain investors entered into a securities purchase agreement pursuant to which Odyssey agreed to sell an aggregate of 700,000 shares of Odyssey’s common stock and warrants to purchase up to 700,000 shares of common stock to such investors. The common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase one shares of common stock. The purchase price for each unit is $7.155.
The warrants have an exercise price of $7.155 per share of common stock and will be exercisable in accordance with their terms at any time on or before the close of business on November 2, 2023. The net proceeds to the Company from the registered direct public offering, after deducting placement agent fees and its estimated offering expenses, and excluding the proceeds, if any, from the exercise of the warrants issued in the offering, are expected to be approximately $4.6 million. The transaction is expected to close on November 2, 2018, subject to satisfaction of customary closing conditions.
Pursuant to a letter agreement dated October 31, 2018, Odyssey has also retained Chardan Capital Markets, LLC (“Chardan”) to act as placement agent, on a nonexclusive basis, in connection with offer and sale of the units. There is no requirement that any minimum number of units or dollar amount of units be sold in this offering, and there can be no assurance that Odyssey will sell all or any of the units being offered.
Odyssey agreed to pay Chardan Capital a placement agent fee equal to 8.0% of the gross proceeds of the sale of the units sold by Chardan in the offering. Odyssey also agreed to reimburse Chardan for up to $25,000 of incurred by it in connection with this offering.
The foregoing summaries of the terms of the purchase agreement, the warrants, and the letter agreement are subject to, and qualified in their entirety by, such documents attached hereto as Exhibits 10.1, 4.1, and 1.1, respectively, and are incorporated herein by reference.
The common stock and warrants are being offered and sold pursuant to a base prospectus and a prospectus supplement, both filed pursuant to Odyssey’s shelf registration statement on FormS-3 (FileNo. 333-227666). The legal opinion and consent of Akerman LLP and the legal opinion and consent of Snell & Wilmer L.L.P. relating to the common stock and warrants are filed as Exhibit 5.1 and Exhibit 5.2 hereto, respectively.
Item 9.01. | Financial Statements and Exhibits. |
| (a) | Financial Statements of Businesses Acquired. |
Not applicable.
| (b) | Pro Forma Financial Information. |
Not applicable.
| (c) | Shell Company Transactions. |
Not applicable.